MICHA GREENLEE: Open Payments
NPI 1821742867 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$678 in 27 payments from 14 companies in 2025. Trend: 2023 $510 · 2024 $968 · 2025 $678
Food & beverage: $678
| Company | Payments | Amount |
|---|---|---|
| SCPHARMACEUTICALS INC. | 3 | $191 |
| Novartis Pharmaceuticals Corporation | 5 | $86 |
| Merck Sharp & Dohme LLC | 4 | $67 |
| AtriCure, Inc. | 1 | $62 |
| Novo Nordisk Inc | 2 | $47 |
| Boston Scientific Corporation | 2 | $37 |
| Kestra Medical Technology Services, Inc. | 1 | $37 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $36 |
| Amgen Inc. | 2 | $28 |
| Abbott Laboratories | 1 | $24 |
Products named: FUROSCIX, LEQVIO, VERQUVO, SYNERGY ABLATION SYSTEM, Assure WCD, REPATHA, Wegovy, THORATEC HEARTMATE 3 LVAS IMPLANT KIT.
Industry payments across KY — which companies pay providers there.
